RVL Pharmaceuticals plc Current Liabilities
RVL Pharmaceuticals plc had Current Liabilities of $68.39 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2023-08-14
- 2023-06-30: Liabilities, Current $68.39M.
- 2023-03-31: Liabilities, Current $16.41M.
- 2022-12-31: Liabilities, Current $19.72M.
- 2022-09-30: Liabilities, Current $21.48M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2023-06-30 | $68.39M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $16.41M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $19.72M 10-Q · filed 2023-08-14 | |
| 2022-09-30 | $21.48M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $18.55M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $21.29M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $20.11M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $53.93M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $265.51M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $48.65M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $55.78M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $54.95M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $58.89M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $58.15M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $75.94M 8-K · filed 2021-09-08 | |
| 2019-09-30 | $78.59M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $97.90M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $96.49M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $114.00M 10-K · filed 2020-03-19 | $114.39M 10-K · filed 2019-03-28 |
| 2018-09-30 | $115.61M 10-Q · filed 2018-11-08 | |
| 2017-12-31 | $124.68M 8-K · filed 2019-12-20 |